opentrade on 
↗
↗event6 outcomes
When will Beam Therapeutics submit a BLA for Risto-cel?
·Science and Technology·ends Apr 8, 2027vol cum
$21.1k
vol 24h
$20
outcomes
6
ends
Apr 8, 2027
outcomesclick to inspect →
showing 5 of 6
marketselected outcome
before April 2027
rank #1
United States
93¢
vol cum
$2.5k
vol 24h
$0
spread
0.07
ends
Apr 8, 2027
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Apr 8, 2027
before April 2027 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWhen will the FDA approve Intellia Therapeutics' lonvo-z?
Before July 202750¢▲ 7.0ppBefore October 202785¢▲ 33.0ppBefore 202872¢· 0.0pp
$1.3k 24h · 3 markets
polymarketFDA approves Retatrutide this year?
yes6¢▲ 2.2pp
$379 24h · 1 market
Will AOH1996 succeed in Phase I trial?
yes72¢
M0 24h · 1 market
kalshiWill the FDA approve retatrutide?
Before Jan 1, 202714¢· 0.0ppBefore Jan 1, 202999¢Before Jul 1, 202887¢
+2 others
$13 24h · 5 markets
polymarketSkin cancer vaccine BLA submitted by...?
June 30, 2027?88¢March 31, 202747¢
$0 24h · 2 markets
Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
yes76¢
M0 24h · 1 market